R1 RCM Inc
NASDAQ:RCM
Relative Value
The Relative Value of one RCM stock under the Base Case scenario is 28.91 USD. Compared to the current market price of 12.36 USD, R1 RCM Inc is Undervalued by 57%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
RCM Competitors Multiples
R1 RCM Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
R1 RCM Inc
NASDAQ:RCM
|
5.2B USD | 2.3 | 1 573.8 | 12.2 | 25.3 | ||
US |
Cigna Corp
NYSE:CI
|
104.5B USD | 0.5 | 20.2 | 10.4 | 13.9 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
96.9B EUR | 0.5 | 20 | 10.3 | 13.7 | |
US |
CVS Health Corp
NYSE:CVS
|
72.5B USD | 0.2 | 8.7 | 7.9 | 7.9 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
22.7B EUR | 1.2 | 45.6 | 10.6 | 25.1 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 1.4 | 39.2 | 11.9 | 18 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 0.7 | -26.5 | 10.1 | 22.6 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.3B USD | 1.6 | 18.1 | 10.8 | 14.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 0.6 | 23.3 | 6.9 | 16.4 | |
US |
DaVita Inc
NYSE:DVA
|
12.4B USD | 1 | 18 | 8.6 | 12.7 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |